Senior Clinical Research Physician, Psychiatry at Bristol-Myers Squibb

Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

In-depth knowledge of etiology, natural history, diagnosis, and treatment of psychiatric disorders
Strong expertise in the disease area through attending scientific conferences and ongoing review of literature
Knowledge of asset/drug, disease area, and relevant science to meet regulatory and disease strategy targets
Awareness of development and regulatory issues related to competitive or relevant compounds and portfolio fit in the competitive landscape
Fulfillment of GCP and compliance obligations, including maintaining all required training

Responsibilities

Contributes to and co-leads high-performing Study Teams (ST) and may serve as a member of the China Development Team (DT)
Leads medical data review of trial data, including eligibility review
Manages site interactions in partnership with global clinical trial physician and/or clinical scientist for medical questions, education, and safety management guidelines
Assesses key safety-related serious adverse events in partnership with Worldwide Patient Safety and oversees safety narratives
Provides inputs into protocols, offering medical strategic oversight on inclusion/exclusion criteria and other safety-related clinical considerations
Provides inputs into clinical plans and protocols with a strong strategic focus, in collaboration with China Development Team
Oversees and holds medical accountability for a group of studies
Leads benefit/risk analysis for clinical development protocols in a matrix team environment
Supports executional delivery of studies (e.g., site activation, enrollment status, adjudication for protocol violations and deviations)
Identifies and builds relationships with principal investigators and cultivates thought leaders for input on emerging science, drug/biomarker research, disease knowledge, and clinical study design
Maintains a strong medical/scientific reputation within the disease area and provides ongoing medical education for protocol-specific training to study teams, investigators, and others
Contributes as medical point of expertise in Health Authority interactions and advisory board meetings
Authors/drafts clinical content for CSRs, regulatory reports, briefing books, and submission documents to support study closure, narratives, reporting, and filing

Skills

Clinical Research

Medical Monitoring

GCP

Protocol Development

Safety Management

Serious Adverse Events

Site Interactions

Psychiatry

Clinical Trials

Data Review

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free